LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS

Clinical trials for LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS explained in plain language.

Never miss a new study

Get alerted when new LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS trials appear

Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill tested to tame painful lupus skin rashes

Disease control Ongoing

This study is testing whether an oral medication called deucravacitinib is safe and effective at reducing skin inflammation in people with discoid or subacute cutaneous lupus. About 74 participants with moderate to severe skin symptoms that aren't well controlled by standard trea…

Matched conditions: LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS

Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS

Get alerted when new LUPUS ERYTHEMATOSUS, SUBACUTE CUTANEOUS trials appear

New pill tested to tame painful lupus skin rashes